News and Announcements
Altech Chemicals Presentation at the 3rd International Sapphire Expo
- Published June 23, 2016 10:42AM UTC
- Publisher Wholesale Investor
- Categories Company Updates
23rd June 2016, ASX Announcement
Altech Chemicals Limited (Altech/the Company) (ASX: ATC) is pleased to provide a copy of the presentation that will be delivered by Company General Manager Operations, Mr Jingyaun Liu at the 3rd International Sapphire Industry Technology Exhibition (Sapphire Expo) in Shenzen, China on Thursday, 23 June 2016.
The Sapphire Expo is an annual trade show that is held over three days (22 – 24 June 2016) and attracts hundreds of sapphire industry participants from around the world. Participants include sapphire glass and wafer manufacturers, sapphire substrate producrers, high purity alumina suppliers, and importantly representatives from the LED lighting and lithium-ion battery manufacturing sectors.
To view the full presentation, please click on the button below.
Company Updates
Capital Is Flowing – Just Not to Everyone: Inside Australia’s $1.8 Billion Q1 2026
Australia’s startup ecosystem opened 2026 with a number that demanded attention. In the first three months of the year, $1.8 billion was raised across 81 venture deals and 26 accelerator rounds. That makes Q1 2026 the strongest start to a year since the 2022 boom, up 63% on Q1 2025, and more than double the […]
The control layer for the electrified home
THE MARKET SHIFT Australian households have been pulled into a real-time energy market they never knowingly signed up for. Flat electricity tariffs are disappearing. In their place: dynamic, time-of-use pricing that changes depending on when power is consumed. Electricity is now cheapest when solar floods the grid in the middle of the day — and […]
500 Million Episodes, Limited Treatment: How Patrys is Bridging the Gap in an Underserved Market
In the clinical vocabulary of the Intensive Care Unit, there is perhaps no word that carries as much quiet dread as delirium. It is a “chemical storm” of the brain—an acute dysfunction where the delicate balance between calming and activating signals is scrambled. For the patient, it can be a waking nightmare of hallucinations and […]
Backed By Leading Investment Groups and Family Offices
